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A screening approach was applied to influent and effluent wastewater samples. After 3 
injection in a LC-LTQ-Orbitrap, data analysis was performed using two deconvolution 4 
tools, MsXelerator (modules MPeaks and MS Compare) and Sieve 2.1. The outputs were 5 
searched incorporating an in-house database of more than 200 pharmaceuticals and illicit 6 
drugs or ChemSpider. This hidden target screening approach led to the detection of 7 
numerous compounds including the illicit drug cocaine and its metabolite 8 
benzoylecgonine and the pharmaceuticals carbamazepine, gemfibrozil and losartan. The 9 
compounds found using both approaches were combined, and isotopic pattern and 10 
retention time prediction were used to filter out false positives. The remaining potential 11 
positives were reanalysed in MS/MS mode and their product ions were compared with 12 
literature and/or mass spectral libraries. The inclusion of the chemical database 13 
ChemSpider led to the tentative identification of several metabolites, including 14 
paraxanthine, theobromine, theophylline and carboxylosartan, as well as the 15 
pharmaceutical phenazone. The first three of these compounds are isomers and they were 16 
subsequently distinguished based on their product ions and predicted retention times. This 17 
work has shown that the use deconvolution tools facilitates non-target screening and 18 
enables the identification of a higher number of compounds. 19 
 20 
Keywords: Non-target screening, peak-picking, hidden target screening, software, high 21 
resolution mass spectrometry, aquatic environment  22 
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Introduction 23 
The investigation of emerging contaminants has become prevalent in analytical 24 
environmental chemistry circles. The use of pharmaceuticals, personal care products and 25 
illicit drugs is increasing worldwide, due to the growing population and the rise in 26 
available products and the amount of these contaminants entering the aquatic 27 
environment is of concern (Fatta-Kassinos et al., 2011). There is no blanket removal 28 
process able to be undertaken by wastewater treatment plants (WWTPs) for all 29 
compounds, leading to poor removal rates and detection of many of these compounds in 30 
effluent wastewaters (EWW) and consequently in surface waters (Bijlsma et al., 2012; 31 
Luo et al., 2014; van der Aa et al., 2013).  32 
High Resolution Mass Spectrometry (HRMS) instruments, such as Time of Flight (TOF) 33 
and Orbitrap have revolutionized the investigation of emerging contaminants in the 34 
aquatic environment due to their high sensitivity in full scan mode, their increased mass 35 
accuracy and the possibility to distinguish the isotopic pattern. HRMS instruments have 36 
the ability to screen for unknowns due to exact mass measurements and these are unique 37 
characteristics compared to other mass spectrometry instruments. Hybrid systems i.e. 38 
HRMS hyphenated to a quadrupole or linear ion trap (LTQ), such as the LTQ-Orbitrap, 39 
combines the tandem mass spectrometric capability associated with the LTQ with the 40 
high mass resolving power (up to 100,000 FWHM) and mass accuracy capability of the 41 
Orbitrap (de Voogt et al., 2011; Makarov and Scigelova, 2010). These hybrid 42 
configurations based on HRMS allow reliable interpretation of MS/MS spectra and are 43 
very valuable when dealing with complex environmental matrices, such as wastewater, 44 
where co-elution of analytes with matrix interferences can result in ambiguous peaks 45 
(Hogenboom et al., 2009). By utilising the ultra-high resolution capabilities, isobaric 46 
compounds can easily be differentiated (Hernández et al., 2012).  47 
In the literature, three different approaches are described for the detection and/or 48 
identification of compounds: target, suspect/post-target and non-target (Aceña et al., 49 
2015; Bletsou et al., 2015; Gago-Ferrero et al., 2015; Hernández et al., 2015b, 2014, 2005; 50 
Krauss et al., 2010; Leendert et al., 2015). Target methods are limited to a restricted 51 
number of compounds, for all of which reference standards must be obtained and, 52 
therefore, information on the occurrence of other unknown, relevant micropollutants may 53 
be missed. Suspect screening takes advantage of a database of “known” compounds, 54 
including molecular formulae, fragmentation and retention time, which can then be 55 
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computationally correlated to spectral HRMS data to give potential positive compounds. 56 
As the concept of suspect screening implies that reference standards are not necessarily 57 
available, the tentative identification of potential positives needs to be confirmed by the 58 
use of reference standards (and MS/MS injections, if required) in a final step.  59 
The third, non-target, approach is of increasing interest but notoriously difficult to 60 
undertake, as, strictly speaking, no a priori information is available  (Krauss et al., 2010; 61 
Schymanski et al., 2014b; Zedda and Zwiener, 2012). Even with the help of automated 62 
peak-picking software, thousands of peaks can be detected in an individual sample (Hug 63 
et al., 2014; Kern et al., 2009). Consequently, subsequent steps must then be made to 64 
reduce the number of peaks to a more manageable number, including molecular formula 65 
derivation, isotopic pattern, mass defect analysis and retention time prediction (Gago-66 
Ferrero et al., 2015; Helbling et al., 2010; Kind and Fiehn, 2007). Further confidence in 67 
the “potential positives” remaining can be gained through the use of fragmentation in a 68 
subsequent MS/MS injection and comparison with in silico fragmentation and/or mass 69 
spectral libraries (Bletsou et al., 2015; Gerlich and Neumann, 2013; Herrera-Lopez et al., 70 
2014; Hug et al., 2014; Little et al., 2012), with the latter referred to as “hidden targets” 71 
(Letzel et al., 2015). In these situations, it is of prime importance and for ease of the 72 
analyst to have software capable of fulfilling most (if not all) of these steps automatically. 73 
Most manufacturers have software specific for their instrument and data, which can 74 
automatically extract analytes of interest from the raw data, to facilitate suspect screening 75 
approaches. However, despite the tremendous advances in software for 76 
metabolite/transformation product detection and further non-target work, sometimes not 77 
all required information is available in one platform, leading users to manufacturer-78 
independent software, such as the Eawag open-source R-code packages enviMass, 79 
enviPick, nontarget and RMassBank (Schollée et al., 2015; Schymanski et al., 2014a) 80 
which can enable the incorporation of additional parameters, such as the steps outlined 81 
above. In spite of these problems, non-target screening is necessary to identify new or 82 
unknown relevant pollutants, which is why efforts need to be made in developing proper 83 
software and efficient identification tools. 84 
This work portrays the combination of non-target data processing and hidden target 85 
searching of environmental water samples after injection in an LC-LTQ-Orbitrap. Two 86 
computational programs were utilized: MsXelerator (MsMetrix) and Sieve 2.1 (Thermo 87 
Scientific). An in-house database of more than 200 pharmaceuticals, personal care 88 
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products and illicit drugs was incorporated in both programs. Additionally, Sieve 2.1 was 89 
used in combination with the ChemSpider search feature. The main objective was to 90 
demonstrate the utility and additional value of these software packages for screening.  91 
This led to the detection of numerous compounds across both programs. The compounds 92 
detected by both methods were then reinjected to obtain MS/MS fragmentation, leading 93 
to the tentative identification of 24 compounds. Ultimately, this work shows that the 94 
combined use of two deconvolution tools combined with two hidden target screening 95 
approaches provides more information than either one used individually.  96 
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2. Materials and Methods 97 
2.1 Reagents  98 
HPLC-grade methanol (MeOH), and formic acid (>98 % w/w) were purchased from 99 
Mallinckrodt Baker (Deventer, The Netherlands). The ultrapure water was obtained by 100 
purifying demineralized water in a Milli-Q system from Millipore (Bedford, MA, USA). 101 
SPE cartridges used were Oasis HLB 3 mL (60 mg) from Waters (Milford, MA, USA). 102 
Polytyrosine-1,3,6 standard used for mass axis calibration was purchased from Cs Bio 103 
Co. (Menlo Park, CA, USA). Mixed cellulose ester membrane filters (0.45 μm) were 104 
purchased from Whatman (Dassel, Germany).  105 
 106 
2.2 Water samples and extraction procedure 107 
Seven influent wastewater (IWW) and seven effluent wastewater (EWW) 24-hour 108 
composite samples were collected over seven consecutive days in March 2014. They were 109 
stored in high density polystyrene bottles, immediately centrifuged and stored in the dark 110 
at -20°C.  Analyses were performed as soon as possible after collection in order to keep 111 
biotic or abiotic degradation to a minimum (Llorca et al. 2014).     112 
A solid phase extraction (SPE) step was applied prior to analysis to pre-concentrate the 113 
samples. All samples were filtered through a mixed cellulose ester membrane filter (0.45 114 
μm). SPE was performed using Oasis HLB cartridges (60 mg). The water samples (EWW 115 
100 mL, with IWW four times diluted (i.e. 25 mL sample diluted to 100mL by adding 116 
Milli-Q water)) were loaded onto the cartridges and reconstructed in 1 mL of 10:90 117 
MeOH:H2O after elution with MeOH (5 mL). A procedural blank was also made, 118 
following the steps above but using Milli-Q water. Analyses were performed by injecting 119 
20 μL of the final extract (in triplicate) into the LC-LTQ FT Orbitrap.  For further 120 
information on the SPE procedure, see (Hernández et al., 2015a).  121 
2.3 Liquid Chromatography  122 
The HPLC system, consisted of a Surveyor auto sampler model Plus and a Surveyor 123 
quaternary gradient HPLC-pump (Thermo Fisher Scientific, Breda, The Netherlands). 124 
Chromatographic separation of the compounds was made using an XBridge C18 column 125 
(150 mm × 2.1 mm I.D., particle size 3.5 µm) (Waters). The pre-column used was a 4.0 126 
mm × 2.0 mm I.D. Phenomenex Security Guard column (Bester, Amsterdam, the 127 
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Netherlands). The analytical column and the guard column were maintained at a 128 
temperature of 21ºC in a column thermostat. A gradient was used at a constant flow rate 129 
of 0.3 mL min−1 using Milli-Q water (Solvent A) and MeOH (Solvent B) both with 0.05% 130 
formic acid. The percentage of organic modifier (B) was changed linearly as follows: 0 131 
min, 5%; 40 min, 100%; 45 min, 100%; 47 min, 5%. Between consecutive runs, the 132 
analytical column was re-equilibrated for 5 min. 133 
2.4 LTQ-FT Orbitrap mass spectrometry 134 
 135 
An LTQ FT Orbitrap mass spectrometer (Thermo Electron, Bremen, Germany) was used. 136 
The LTQ part of this system was equipped with a Heated Ion Max Electrospray Ionization 137 
(HESI) probe and operated in the positive ion mode. The conditions were: source voltage 138 
3.0 kV, heated capillary temperature 300ºC, vaporizer temperature 350ºC, capillary 139 
voltage 13 V and tube lens 70 V. Products ions were generated in the LTQ trap at a 140 
normalized collision energy setting of 35% and using an isolation width of 2 Da. 141 
 142 
Full-scan accurate mass spectra (mass range from 50 to 1300 Da) were obtained at a mass 143 
resolution of 60,000. The total cycle time depends upon the resolution; at the selected 144 
resolution the total cycle time is 0.5 s. The instrument was initially set to operate in full-145 
scan (‘survey’) mode with accurate mass measurements. When an ion exceeded a preset 146 
threshold, the instrument switched to product-ion scan mode in the ion trap part. Further 147 
details on instrument operating conditions can be found elsewhere (Bijlsma et al., 2013) 148 
 149 
All data were acquired and processed using Xcalibur version 2.1 software. A second 150 
MS/MS injection was made by incorporating an inclusion list of masses (see Supporting 151 
Information (S.I.) Table S1 for list) with a retention window of ±2 minutes and collision 152 
energy of 35%. Since MS/MS fragmentation was carried out in the ion trap, only nominal 153 
mass was measured.  154 
 155 
Mass axis calibration was performed with every batch run just prior to starting the batch 156 
by using flow injection of a polytyrosine-1,3,6 solution ([M+H]+ 182.01170/508.20783 157 
and 997.39781) at a flow rate of 10 µL min−1 . 158 
 159 
 160 
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2.5 Settings of the Deconvolution Tools  161 
MsXelerator (MsMetrix) 162 
MS Compare and MPeaks are modules within MsXelerator. MS Compare is specifically 163 
designed for comparing MS spectra, whereas the MPeaks module picks peaks, with the 164 
“keep largest C13 peaks only” and the “peak cluster” algorithms used to help discard 165 
some, the latter performing componentization which groups together all peaks (i.e. 166 
isotopes and adducts) arising from a single retention time (Table S2). All samples were 167 
uploaded individually and later investigated as triplicates, corresponding to the three 168 
triplicate injections of each sample. Procedural blank samples were initially processed 169 
using the optimized software settings (see below) to subtract identical peaks from each 170 
wastewater sample. 171 
The “peak picking” was carried out by MPeaks on each individual sample using the 172 
following parameters and values: Base peak width =11 (arbitrary units); spike width = 5 173 
scans; peak separation = 5 scans; peak threshold = 0.5% (vs. largest peak); smoothness 174 
threshold = 0.65%, signal/noise ratio = 20. The sensitivity value, which helps the user 175 
find more or less sensitive parameters for the previous three parameters, was set  relatively 176 
low, at 2 (out of a maximum setting of 6). The peaks picked using these parameters were 177 
further reduced by only keeping peaks relating to an [M+H] + charge state.  178 
Using the second module, MS Compare, all samples were subjected to the following 179 
LC/MS settings (in accurate mass mode) of the module for peak picking across multiple 180 
samples: No baseline correction; FWHM (scans) = 3 (min) - 40 (max); min peak height 181 
= 10,000 counts; delete spikes; m/z range: 100-650; Max. shift between peaks for 182 
grouping: 20 scans; Time window for XIC: 0.25min; Mass accuracy: 10 ppm.  183 
Sieve 2.1 (Thermo Scientific) 184 
Sieve 2.1 combines the power of the two modules from MsXelerator. After an initial 185 
peak-picking process using the settings described below, it compares MS spectra of the 186 
procedural blank samples and the studied wastewater samples. Only compounds with an 187 
m/z between 150 and 500, and only protonated molecules ([M+H]+) were considered. The 188 
list of potential positives were then search by either the in-house database or ChemSpider, 189 
which were incorporated in the software. The results of the ChemSpider search were 190 
exported into Microsoft Excel, and positive “hits” were considered based on their mass 191 
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error (< 2 ppm), and if the compound commercially existed i.e. hits which only 192 
represented chemical formula were excluded. 193 
The “control compare trend” feature of Sieve 2.1 (Thermo Scientific) was used with the 194 
following parameters: peak intensity threshold = 250,000 (62,500 for IWW); m/z range 195 
= 100-650; m/z width = 10ppm; retention time range = 3-40 minutes; maximum number 196 
of frames = 5,000; frame time width = 1.00 minute; align bypass = true. For the hidden 197 
target screening, either the database used in the analyses of MPeaks and MS Compare or 198 
ChemSpider was incorporated.  199 
2.6 General workflow 200 
The general workflow followed in this work (pictorialized in Figure 1) falls into the 201 
“hidden target” area of non-target screening, hypothesized by Letzel et al. (Letzel et al., 202 
2015), wherein non-target techniques (i.e. peak picking) are originally applied, but a 203 
database (i.e. in-house database or ChemSpider) is used for identification.  204 
All samples were injected in triplicate and the data were processed with the different 205 
software packages of MsXelerator or Sieve 2.1. Only peaks in all three injections were 206 
further investigated. This resulted in a list of chromatographic peaks, based on the 207 
accurate masses of their protonated molecules. To gain a list of potential positives, two 208 
hidden target identification methods were used: 1) an in-house database, containing more 209 
than 200 parent compounds and metabolites and the online database ChemSpider. False 210 
positives were manually removed after investigating the isotopic pattern (for the 211 
characteristic patterns of sulfur- and chlorine-containing species) and retention time 212 
prediction. A final “target list” was investigated by reinjecting the samples in MS/MS 213 
mode, to get product ions. Fragmentation was then compared with online databases and 214 
literature, which allowed the tentative identification of several compounds.  215 
  216 
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3. Results and Discussion 217 
In this study, in order to show the progression through confidence levels of identification, 218 
the terminology proposed in the literature by Hernández et al. (Hernández et al., 2015) 219 
and Schymanski et al. (Schymanski et al., 2014) were followed. It must be noted that 220 
potential positives and detected compounds, differentiated in this work, would both be 221 
level 3 tentative candidate in the terminology of Schymanski et al. The final, tentatively 222 
identified compounds are of a higher confidence level (level 2a). However, in order to 223 
have total confirmation (level 1), reference standards are necessary. As no reference 224 
standards were utilized in this work, this level could not be attained. 225 
3.1 Optimization of the workflow 226 
All samples were injected and processed in triplicate, which were compared together, 227 
with only peaks in all three injections being further investigated.  Procedural blank 228 
samples were processed first, to subtract identical peaks from each subsequent IWW and 229 
EWW sample.  230 
The m/z range of MS Compare was made quite narrow as the compounds of interest in 231 
this study and in the in-house database (small pharmaceutical/drug molecules) would be 232 
within that range. The retention time range was reduced just to 3-40 mins to reduce the 233 
likelihood of erroneously detecting species that elute very early and late due to the 234 
high/low ratio of organic modifier, with the vast majority of all peaks in the total ion 235 
chromatogram falling within this range. In spite of the known mass accuracy capability 236 
of the Orbitrap, the mass accuracy was set at 10ppm to ensure that no compound would 237 
be missed. After this processing, a list of masses common within each triplicate set was 238 
made, with compounds being detected using the same peak peaking parameters and 239 
database used in the final step of the MPeaks analysis. 240 
Sieve 2.1 used the same m/z range, m/z width and retention time range as MS Compare 241 
for better ease of results comparison. The peak intensity threshold was originally set quite 242 
high for both IWW and EWW samples, but it was later found that IWW gave fewer peaks, 243 
possibly due to the complexity of these samples and stronger matrix effects, mostly 244 
leading to ionization suppression. The threshold was thus reduced to one quarter to 245 
account for this. The maximum number of components was raised to 10,000 to ensure 246 
that no compounds would be missed, leading to more than 5,000 components being 247 
detected in the IWW and EWW samples (Table 1). These were reduced by including 248 
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compounds with only a m/z 150-500 and [M+H]+ =1.  The in-house database used by the 249 
previous two modules within the “Accurate Mass Identification Parameters” of Sieve was 250 
then used to gain a list of potential positives.  251 
The ChemSpider database (with 10ppm mass accuracy threshold) was also used within 252 
Sieve and was begun after the initial component optimization was completed (Figure 2). 253 
The threshold was made quite high, for optimal “hidden target” analysis, where the 254 
detected peaks should correspond to compounds which are commonly and/or highly used. 255 
The peak lists of both IWW and EWW results with all data pertaining to mass error, m/z 256 
and intensity were exported into Microsoft Excel. From these lists, several thresholds 257 
were set and outlying peaks removed: only compounds between m/z 150-500; only 258 
[M+H]+; mass error under 2.0ppm; all “hits” just representing a chemical structure, rather 259 
than a generic/known name. This final step is rather pragmatic but makes for a more 260 
optimal non-target screening, where the remaining compounds should be the more 261 
common and/or highly used, as emphasized by having a high intensity threshold. 262 
However, this could lead to some less intense peaks being missed and not noted as a 263 
possible emerging contaminant in the environment.  264 
 265 
3.2 Identification with in-house database 266 
Both programs incorporated an in-house database of more than 200 pharmaceuticals, 267 
illicit drugs and metabolites (Table S3) to get a list of potential positives. All samples 268 
were first processed with MsXelerator (modules MPeaks and MSCompare) and Sieve 2.1 269 
using the parameters outlined in Section 2.5. Table 2 shows the compounds detected by 270 
each.  271 
There was very little difference between the compounds found with Sieve and MS 272 
Compare, while MPeaks detected somewhat fewer compounds. This could be due to their 273 
apparent uses: MPeaks is for pick-peaking, MS Compare for comparing samples, while 274 
Sieve does both, resulting in the latter two have more similar results. The fact that all 275 
compounds detected by MPeaks were also found with MS Compare leads to the 276 
preferential use of the latter module for screening. However, by optimizing the peak-277 
peaking parameters of MPeaks, specifically the sensitivity value, this module could also 278 
be of future use in suspect and/or non-target screening.  279 
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Two methods were used to remove potential false positive peaks: isotopic pattern (for 280 
chlorine- and sulfur-containing species) and retention time prediction. Only three of the 281 
above compounds (losartan, sulfamethoxazole and temazepam) had a chlorine or sulfur 282 
atom, giving rise to a characteristic isotopic pattern. Extracted ion chromatograms were 283 
extracted from the initial full-scan data of the Orbitrap and investigated manually. Both 284 
sulfamethoxazole and losartan showed the characteristic isotopic pattern, while 285 
temazepam did not. Temazepam was thus considered as a false positive and removed 286 
from further investigation. 287 
A retention time predictor was made, based on artificial neural networks, as in (Miller et 288 
al., 2013; Munro et al., 2015) and in our previous work (Bade et al., 2015a).    A retention 289 
time window of ±11% of total run time was used to find compounds to focus on, based 290 
on the window used in our previous work. Of the 25 potential positives investigated, four 291 
were removed using this method (benzocaine, ibuprofen, lincomycin and salbutamol) 292 
with predicted retention times between 11.5-16.8 minutes (24-36% of the total run time) 293 
away from the experimental times. While only four compounds were removed using this 294 
technique, it does simplify the identification process, and provides greater confidence in 295 
the compounds remaining.  296 
3.3 Identification with ChemSpider 297 
To make a more comprehensive analysis of the samples, an investigation was made using 298 
the ChemSpider database search feature of Sieve (Figure 2).. The introduction of 299 
ChemSpider, while removing many components, had the added complication of isobaric 300 
and isomeric compounds, with most distinct m/z values having more than one compound 301 
associated, as seen in step 5 of Table 1.  To further refine this list, the mass error was 302 
limited to 2ppm (step 6) and all compounds having a formula-only entry were deleted, 303 
leaving just compounds with generic names (step 7), leaving up to 100 components in the 304 
samples. The literature was then searched to determine whether or not their detection in 305 
wastewater could be expected,  leading to approximately 30 components and up to 34 306 
isomeric/isobaric compounds in the samples. The literature search was made using the 307 
Scopus database, and search terms were the generic name of interest, “HRMS”, “LC”, 308 
“environment” and “water”. If there were no suitable papers concerning the generic name 309 
of interest, the compound was removed from further investigation. To determine which 310 
of the isomeric/isobaric compounds the compound within the sample was, the molecular 311 
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formula was manually searched on ChemSpider, with the compound having the highest 312 
number of references deemed to be the compound of interest. Step 7 and the literature 313 
search, while pragmatic, were employed to ensure that the compounds detected were 314 
those of high consumption/prescription and could therefore be more easily identified in 315 
the later in silico fragmentation comparison. Finally, eighteen (including three isomers) 316 
and eight compounds were finally deemed as potential positives using this non-target 317 
approach for IWW and EWW samples respectively (Table S4).    318 
It is worth noting that by using this approach, most of the same compounds were found 319 
as with the in-house database (Table 2 and S4). With such great similarities between the 320 
set of potential positive compounds, only 2-hydroxy carbamazepine, desvenlafaxine, 321 
adenosine, albendazole, phenazone and the three isomers theophylline, paraxanthine and 322 
theobromine required further investigation. Albendazole was the only compound that 323 
required an investigation of isotopic pattern as it contains one sulfur atom, which was 324 
inconsistent with the mass spectrum, leading to its removal as a false positive. The 325 
remaining seven compounds were subjected to retention time prediction based on the time 326 
given by Sieve 2.1, and all were found within the set ±11% of total run time retention 327 
time window.  328 
3.4 Tentative identification  329 
The potential positives found using both hidden target screening approaches were 330 
combined, less those removed in previous steps, leaving 28 compounds to investigate 331 
(Table S1). These compounds were added to a target list and several IWW and EWW 332 
samples were reinjected to see if fragment ions from these compounds could give further 333 
confidence to their identification. Metfusion and MassBank were used to help provide 334 
further confidence to the fragment ions. As has been mentioned in previous suspect and 335 
non-target studies (Agüera et al., 2013; Herrera-Lopez et al., 2014; Zedda and Zwiener, 336 
2012), the use and improvement of mass spectral databases, such as MassBank, is 337 
extremely important in the tentative identification of compounds for which standards are 338 
unavailable. In the end, 22 compounds were able to be tentatively identified (Table 3) 339 
with at least one fragment ion, while the other six were removed as false positives due to 340 
having incorrect fragment ions.  341 
One interesting finding was the detection of three isomers (paraxanthine, theobromine 342 
and theophylline). These three isomers are all metabolites of caffeine, accounting for 343 
Page 14 of 26 
 
80%, 11% and 4% of total metabolism, respectively (Miners and Birkett, 1996). 344 
Conventionally, isomeric compounds, separated chromatographically, would be 345 
distinguished by retention time. However, as no standards were available, the best way to 346 
order the peaks was with retention time prediction. The approach outlined in Sieve 2.1 347 
combines the power of the two modules from MsXelerator as described above. After an 348 
initial peak-picking process using the settings described in Section 2.5, it compares MS 349 
spectra of the procedural blank samples and the studied wastewater samples. Only 350 
compounds with an m/z between 150 and 500, and only protonated molecules ([M+H]+) 351 
were considered. The list of potential positives were then search by either the in-house 352 
database or ChemSpider, which were incorporated in the software. The results of the 353 
ChemSpider search were exported into Microsoft Excel, and positive “hits” were 354 
considered based on their mass error (< 2 ppm), and if the compound commercially 355 
existed i.e. hits which only represented chemical formula were excluded.  predicted 356 
retention times of 8.48 min, 9.34 min and 9.41 min for theobromine, paraxanthine and 357 
theophylline, respectively. While these times are 1-2 minutes from the experimental 358 
retention time, they do provide an idea for the order of the isomers. To give more 359 
confidence to this information, the fragment ions were checked. As seen in Figure 3, the 360 
peak at 6.27 min had fragment ions of m/z 163 and 138 while the peaks at 7.98 and 8.37 361 
both had one major peak of m/z 124.  These fragment ions were checked and compared 362 
with MassBank and the literature (Bianco et al., 2009; Gómez et al., 2010; Horai et al., 363 
2010).. Theobromine was found to have fragment ions of m/z 163 and 138, while both 364 
paraxanthine and theophylline were found to have a main fragment ion of m/z 124. The 365 
losses leading to each fragment ion is defined in Figure 3. To differentiate the latter two, 366 
the initial retention time predictions led to paraxanthine being the larger peak at 7.98 min 367 
and theophylline the small peak at 8.37 min.  368 
While 22 compounds were tentatively identified using the workflow outlined throughout 369 
this paper, it must be noted that even incorporating the false positive removal strategies 370 
of retention time prediction and isotopic pattern as well as fragment ions, the final 371 
confirmation of the identity of compounds requires the use of reference standards.  372 
Nevertheless, the addition of advanced deconvolution tools (MsXelerator and Sieve) to 373 
the HRMS data of the Orbitrap has been shown to be of great value, and the results show 374 
how far one can go without the need to purchase reference standards. The information 375 
obtained with this strategy circumvents the cost and problems associated with the storage 376 
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and expiry dates of standards in the laboratories, as the purchase can be directed only 377 
towards those compounds that have been previously tentatively identified in the samples. 378 
379 
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Conclusion 380 
This work has shown that, following initial unbiased, non-target oriented deconvolution 381 
using two tools(MsXelerator and Sieve), allowed relevant peaks of interest to be attained. 382 
The complementary use of an in-house database or ChemSpider facilitated detection and 383 
enabled the identification of more compounds than using just one of these databases.  384 
The combination of deconvolution tools and high resolution mass spectrometry, without 385 
the use of any reference standards, has enabled 22 compounds to be tentatively identified 386 
in environmental water samples. The majority of compounds that were identified in 387 
wastewater samples were pharmaceuticals, including the metabolites 4-formylamino 388 
antipyrine, 4-acetylamino antipyrine, theobromine, theophylline, paraxanthine and 389 
carboxylosartan.  390 
It is worth noting that the two hidden target approaches primarily found the same 391 
compounds, with some exceptions. Furthermore, when applying small databases it is 392 
often easier to analyse the raw data directly. Whereas, when a much larger database is 393 
incorporated, these software tools will facilitate searching as well as reducing processing 394 
time. With further improvements to these computational programs non-target analysis 395 
will become more enticing and easier for laboratories to use in everyday screening 396 
methods.  397 
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Table 1: Number of components after each step of the Sieve hidden target identification approaches..  566 
 567 
 568 
Step IWW components EWW components 
1. 6690 5091 
2. 5158 3528 
3. 2014 2175 
4.  18 16 
NON-TARGET SCREENING 
Number of distinct m/z (total number of compounds) 
5. 239 (437) 441 (677) 
6. 166 (362) 308 (543) 
7. 100 (150) 64 (108) 
Final 18 8 
 569 
570 
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Sieve MSCompare Mpeaks 
 
Sieve MSCompare Mpeaks 
4-acetylamino 
antipyrine 
       
4-formylamino-
antipyrine 
       
Acetaminophen        
Benzocaine        
Benzoylecgonine        
Caffeine        
Carbamazepine        
Cocaine        
Cotinine        
Gemfibrozil        
Ibuprofen        
Irbesartan        
Ketoprofen        
Lidocaine        
Lincomycin        
Losartan        
Metoprolol        
Naproxen        
Phenacetin        
Phenytoin        
Salbutamol        
Sulfamethoxazole        
Temazepam        
Trimethoprim        
Valsartan        
 
572 
 Detected by the program 
 Not detected by the program 
 
573 
  574 
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Table 3: All compounds tentatively identified (level 2a), together with retention time and fragment ions 575 
RT = retention time (minutes) 576 
The parent ions were recorded at accurate mass (full-scan mode) while the fragment 577 
ions were recorded as part of a product ion scan in the ion trap part with nominal mass 578 
measurement.  579 
1 Information on fragment ions from Hernández et al (Hernández et al., 2015a) 580 
2 Information on fragment ions from MassBank (Horai et al., 2010) 581 
3 Information on fragment ions from Bade et al (Bade et al., 2015b)  582 
4 Information on fragment ions from Gómez et al (Gómez et al., 2010) 583 
 584 
Compound m/z RT Fragment ions  IWW  EWW  
        
4-acetylaminoantipyrine1 246.1234 9.43 228.1 204.1 
 
X X 
4-formylaminoantipyrine2 232.1086 9.29 214.1 204.1 
 
X X 
Acetaminophen3 152.0706 6.09 110.1 134.0 
 
X X 
Adenosine2 268.1035 3.58 136.0 
   
X 
Benzoylecgonine2 290.1385 12.22 168.1 
  
X X 
Caffeine1 195.0876 10.4 138.1 
  
X X 
Carbamazepine3 237.1022 22.56 194.1 152.9 
 
X X 
Carboxylosartan1 437.1480 26.94 207.1 235.1 365.3 X X 




Ketoprofen3 255.1014 16.78 237.1 209.1 
 
X X 




Losartan1 423.1695 25.58 405.0 207.2 377.2 X X 
Metoprolol2 268.1908 13.71 218.1 191.1 159.1 X 
 
Naproxen3 231.1016 27.24 185.1 
  
X X 
Paraxanthine2 181.0721 7.98 124.1 
  
X X 
Phenacetin2 180.1030 17.22 138.1 110.0 
 
X X 
Phenazone2 189.1022 12.15 161.2 146.1 131.1 X X 
Sulfamethoxazole2 254.0594 12.41 235.8 188.1 156.1 X X 
Theobromine2,4 181.0721 6.28 163.1 137.1 138.1 X X 
Theophylline2,4 181.0721 8.37 124.1   X X 
Trimethoprim2 291.1454 9.91 230.2 123.2 261.1 X X 
Valsartan2 436.2341 28.96 335.1 265.2 155.1 X X 




Figure 1: Workflow for screenings using the deconvolution tools MsXelerator and Sieve. All orange levels 587 
represent specific identification confidence levels 588 
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 595 
Figure 3: Tentative identification of theobromine (top left), paraxanthine (bottom left) and theophylline 596 
(bottom right), with chromatographic peaks (top right). The generic structure has been shown in the top 597 
right corner, where R1, R2 and R3 differ for the metabolites as follows: theobromine: R1 =CH3, R2 = CH3 598 
and R3 = H; theophylline: R1 =H, R2 = CH3 and R3 = CH3; paraxanthine: R1 =CH3, R2 = H and R3 = CH3 599 
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